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Naturally occurring  antigens of biologic importance (e.g.,  bacteria, viruses,  bac- 
terial toxins)  in general  contain numerous antigenic determinants. An understanding 
of the control of antibody formation to such antigens thus requires a knowledge of the 
behavior of multiple  antigenic  determinants  when  presented  simultaneously.  It is 
well known that the simultaneous presentation of two antigens may result in a  de- 
crease in the amount of antibody formed to one or both antigens.  Previous studies on 
this phenomenon, generally referred to as "antigenic competition," have been exten- 
sively reviewed  by Adler  (1,  2).  The mechanism of  antigenic  competition is  still 
unknown. 
It is  well  established  that passively administered antibody can cause  a  specific 
suppression  of active antibody synthesis (3-8). It has been postulated by Uhr (3, 4) 
that  the suppression  of active antibody synthesis by circulating antibody plays an 
important role in the control of antibody formation. While not definitively  proved, it 
is generally assumed that the suppressive effect of passive antibody is the result of its 
ability to bind antigen and thus prevent it from stimulating active antibody synthesis. 
The studies reported here are aimed at gaining greater insight into the mech- 
anisms involved in antigenic competition and suppression and how these factors 
might be connected with the control of antibody synthesis in systems involving 
multiple  antigenic  determinants.  Antibody  formation  against  two  haptenic 
determinants located either on the same or on different carrier molecules was 
studied. The effect of passive antibody against one determinant upon antibody 
synthesis to each haptenic determinant was observed. In the system studied the 
degree of antigenic  competition was the  same whether  the  two haptens were 
present on the same or on different carrier molecules. It was further found that 
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passive  antibody  to  one hapten  resulted  in suppression  of antibody formation 
against that determinant without affecting the antibody production against the 
second determinant,  provided the  two determinants  were on the same  carrier 
molecule.  When  the  two  determinants  were  on  different  carrier  molecules, 
suppression  of  synthesis  of  one  antibody  with  passive  antiserum  resulted  in 
increased formation of antibody against the second hapten. 
Materials and Methods 
Ani~nals.--New Zealand rabbits weighing from 2 to 2.5 kg were used throughout. 
Antigens.--Diifitrophenylated  (DNP)  proteins  were prepared  as  Eisen et  al.  described 
(9-11), by reacting the protein with 2,4-dinitrobenzene sulfonlc acid at room temperature 
under alkaline conditions. The product was purified by repeated acid precipitation followed 
by extensive dialysis. 
Arsenllic acid derivatives (R-Azo) of proteins were prepared as follows. 0.26 g of p-arsenilic 
acid, 0.02 g of KBr, and 1.5 ml of 2 N HC1 were dissolved in 34 ml of distilled water and held 
in an ice-salt bath. 0.085 g of NaNO2 dissolved in 2.5 ml of cold distilled water was added to 
the solution of arseniUc acid with stirring over a 5 min period. The resulting solution was kept 
cold and immediately added, dropwise, over a  15 rain period with continuous stirring, to a 
solution of 2.5 g of protein in 250 ml of 0.1 ~ borate buffer, pH 8.0. The reaction was carried 
out in the cold and the pH was maintained between 9.0 and 9.5 by addition of 1 N NaOH. 
Mter dialysis against phosphate-buffered saline (PBS: 0.15 ~ NaCI, 0.01 ~  phosphate buffer, 
pH 7.4) the derivatized protein was precipitated by acidification of the solution to pH 3.5 
with 5 ~  acetic acid. The precipitate was collected by centrifugation and dissolved in a  1:1 
mixture of ethanol and PBS (0.15 z~ NaC1, 0.01 ~ phosphate buffer, pH 7.4). Acid precipitation 
and  resolution were repeated four times and  the final product was dissolved and  dialyzed 
against multiple changes of PBS. 
When doubly conjugated proteins were prepared,  DNP groups were first coupled to the 
protein followed by coupling of R-Azo groups. 
The concentrations of hapten-conjugated proteins were determined by drying known vol- 
umes to constant weight at 95-100°C. The "dry weights" so obtained were corrected for the 
weight of buffer present. The degree of DNP substitution was estimated spectraUy by assum- 
ing that all hapten groups were coupled to C-amino groups of lysine and by using the molar 
absorbancy of free e-DNP-L-lysine [17,530 at 360 m# (12)]. The degree of substitution of R-Azo 
derivatives was very roughly estimated (13) from their absorbancy in alkali at 500 mtz, assum- 
ing all R-Azo groups were coupled to tyrosine residues.  The values reported for the degree of 
substitution  are admittedly only rough estimates. However. since one ureuaration  of each 
antigen was used throughout and none of the conclusions arrived at required accurate knowl- 
edge of the degree of substitution, the use of more critical methods for estimating the extent 
of substitution was not deemed necessary. 
The following compounds were prepared  (subscripts refer to estimated numbers of groups 
per molecule of protein assuming a molecular weight of 150,000 for bovine and rabbit gamma 
globulin and  330,000  for bovine fibrinogen): dinltrophenylated bovine fibrinogen (DNP150- 
BF),  dinitrophenylated  bovine gamma  globulin  (DNP60-BGG and  DNP~-BGG),  dinitro- 
phenyiated  rabbit  gamma  globulin  (DNP28-RGG),  arsenilate-azo-rabbit  gamma  globulin 
(R-Azo~-RGG), arsenllate-azo-bovine gamma globulin (R-Azols-BGG), rabbit gamma globu- 
lin substituted  with both arsenilate  and  DNP  groups  (R-Azol~-DNP27-RGG), and  bovine 
gamma globulin substituted with both arsenilate and DNP groups (R-Azo16-DNP~t-BGG). 
Quantitative precipitin reactions were carried out on serum from animals immunized with 
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R-Azou-DNP~a-BGG, DNPm-BGG, and R-Azols-BGG were used as precipitating antigens. 
The amount of antibody precipitated by R-Azo~-DNPzl-BGG was always equal to the sum 
of the amounts of antibody precipitated with DNPs1-BGG and with R-Azols-BGG, whether 
the  precipitation reactions with  DNP~t-BGG  and  with  R-Azo~-BGG were carried  out  on 
separate  aliquots  of serum or sequentially on the  same serum sample.  It  should  be  noted 
further  that,  by spectral analysis,  the  doubly coupled antigen  (R-Azols-DNPzT-RGG) was 
completely preeipitable by either purified anti-DNP antibody or purified anfi-arsenilate anti- 
body under conditions of antibody excess. 
Immunization Procedures.--Rabbits were immunized by a single injection of 5 mg of antigen 
emulsified in complete Freund adjuvant. The  antigens used  for immunization were DNP2s- 
RGG, R-Azo~-RGG, and R-Azo~-DNP27-RGG (RGG coupled with both DNP and R-Azo 
haptens). The antigen was administered in a total volume of 2.5 ml divided equally among the 
four foot pads and the back of the neck. Animals were bled 13 and 20 days after antigen injec- 
tion. When animals were to be immunized with two haptens coupled to different carrier mole- 
cules, the two antigens were mixed before emulsification and 5 mg of each antigen was admin- 
istered. 
When passive antibody was to be administered, it was, in all cases,  given intravenously 1 
day prior to injection of antigen. Antiserum used for suppression was pooled antiserum  ob- 
tained from groups of 5-15 rabbits bled either 4 wk after immunization with DNPr0-BGG, or 
3 wk after immunization with R-Azo~-RGG, or 6 wk after immunization with R-Azo~-BGG. 
Details are indicated in legends to the appropriate tables. 
PrecipitaJion Reaztions.--Antibody  measurements were in all cases carried out by quantita- 
tive precipitation reactions (9, 14), using R-Azojz-B  GG and  DNP150-BF as precipitating anti- 
gens. Reaction mixtures were incubated at 37°C for 1 hr and were then held at 4°C  for 24 hr 
before assay. Washed specific precipitates were dissolved in 0.02 ~  sodium lauryl sulfate  (re- 
crystallized from 95% ethanol before use)  and assayed spectrally. Antibody  concentrations 
were determined from the 278 m/z absorbancy of the dissolved specific  precipitates after cor- 
rection for the absorbancy contributed by the antigen. This was calculated  from the absorb- 
ancy of the dissolved specific precipitates at 360 m# in the case of DNP~0-BF and 400 m/z in 
1%  the case of R-AzOls-BGG.  E1 am at 278 m# for rabbit  antibody was taken as 14.0. Complete 
precipitin curves using at least five different amounts of antigen were determined for each 
serum sample. The results reported are the amounts of antibody per rnill~Hter of serum pre- 
cipitated at the peak of the precipitin curves. To permit more accurate analysis, for the pre- 
cipitation reactions we chose antigens which characteristically exhibit long, fiat, equivalence 
zones with little inhibition in antibody excess  (15). 
RESULTS 
The  immune  response  of normal  rabbits  to  R-Azo12-RGG,  DNP~-RGG, 
mixtures of R-AZOlz-RGG and I)NP~8-RGG, and to the doubly coupled antigen 
R-AZOls-I)NPsT-RGG is indicated in Table I. The data  are expressed  as  milli- 
grams of antibody per milliliter of serum as determined by quantitative precipi- 
tin  reactions  using  I)NP~s0-BF  or  R-Azo~5-BGG  as  antigens.  With  RGG  as 
carrier,  animals would be expected to make little or no antibody specific for the 
carrier molectfle itself and on testing of several samples, the amounts of antibody 
precipitable with DNPgs-RGG  and with DNP150-BF  were essentially identical. 
Nevertheless,  in order to ensure  that only antihapten  antibody was measured, 
precipitin reactions were carried out with the hapten attached to carriers differ- 
ent from those used for immunization.  From the data reported in Table I, it is Antigen 
R-Azo-RGG 
Average 
DNP-RGG 
Average 
R-Azo-RGG 
+ 
DNP-RGG 
Average 
R-Azo-DNP-RGG 
Average 
TABLE I 
A ntibody Response  of Normal Rabbits  to 2,4-Dinitrophenyl 
and Arsenilate  tta ~tenic Determinants* 
Rabbit 
No. 
1-78 
1-79 
1-80 
1-81 
1-82 
1-85 
1-86 
1-87 
1-88 
1-89 
1-90 
1-91 
45 
46 
47 
48 
49 
35 
36 
37 
38 
39 
1-06 
1-07 
1-08 
1-09 
1-10 
1-26 
1-27 
1-28 
1-29 
1-30 
Day  13 
Anti-DNP  Anti-R-Azo 
mg/ml  mg/ml 
--  0.76 
--  0.85 
--  0.55 
--  0.59 
--  0.74 
--  0.70 
0.66 
0.94 
1.82 
0.54 
0.62 
0.63 
0.61 
0.83 
O. 18  O. 09 
O. 23  0.07 
0.58  0.18 
0.36  0.09 
0.21  0.13 
0.31  0.11 
0.18  0.22 
0.34  0.13 
0.07  0.09 
0.16  0.13 
0.51  0.23 
0.10  0.03 
0.30  0.07 
0.10  0.00 
0.51  0.10 
0.58  0.18 
0.13  0.00 
0.31  0.07 
0.19  0.00 
0.46  0.08 
0.96  0.06 
0.33  0.09 
Anfi-DNP 
mg/ml 
0.94 
1.76 
0.61 
0.56 
0.97 
0.32 
0.30 
0.55 
0.36 
0.12 
0.33 
0.53 
0.55 
0.19 
0.52 
0.48 
0.15 
0.52 
0.21 
0.56 
0.73 
0.14 
0.19 
0.42 
0.79 
0.99 
0.46 
Day 20 
Anti-R-Azo 
mg/ml 
0.86 
1.10 
0.66 
1.38 
0.50 
0.90 
0.04 
0.10 
0.12 
0.10 
0.04 
0.08 
0.31 
0.23 
0.19 
0.21 
0.13 
0.02 
0.06 
0.00 
0.07 
0.06 
0.00 
0.04 
0.00 
0.04 
0.09 
0.10 
* Animals  immunized with the antigen or mixture of antigens indicated and 
20 days after immunization. 
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clear that  a  marked degree of antigenic competition exists between  the DNP 
and the R-Azo haptenic determinants. Presentation of the two haptens simul- 
taneously  results  in  approximately  a  60%  decrease  in  anti-DNP  antibody 
synthesis and a  90 %  decrease in anti-R-Azo antibody synthesis. Thus,  in this 
TABLE II 
Effect of Anti-DNP Antibody upon the Response of Rabbits to Dinitrophenyl 
and A rs~ailate Ha ~temic Determlnants* 
Antigea 
R-Azo-DNP-RGG 
Average 
R-Azo-RGG 
+ 
DNP-RGG 
Average 
Rabbit 
No. 
4O 
41 
42 
43 
44 
1-11 
1-12 
1-13 
1-14 
1-21 
1-22 
1-23 
1-24 
1-25 
50 
51 
52 
53 
54 
Day 13 
Anti-DNP  Anti-R-Azo 
mg/ml  mg/ml 
0.01  0.00 
0.03  0.34 
0.05  0.00 
0.07  0.22 
0.02  0.04 
0.I0  0.03 
0.I1  0.16 
0.19  0.37 
0.12  0.03 
0.05  0.14 
0.04  0.12 
0.00  0.06 
0.07  0.16 
0.05  0.07 
0.07  0.12 
0.09  0.31 
0.06  0.16 
0.02  0.25 
0.09  0.25 
0.06  0.26 
0.06  0.25 
Day 20 
Anti-DNP  Anti-R-Azo 
mg/ml  rag/ml 
0.04  0.03 
0.06  0.08 
0.37  0.50 
O. 15  0.22 
0.01  0.13 
0.05  0.02 
0.06  0.06 
0.57  O.04 
0.01  0.02 
0.05  0.05 
0.09  0.12 
0.05  0.04 
0.11  0.07 
0.04  0.05 
0.12  0.i0 
0.23  0.20 
0.18  0.19 
0.02  0.23 
0.21  0.19 
0.23  0.24 
0.17  0.21 
* 20.4 mg anti-DNP antibody given intravenously on day before immunization with the 
antigen indicated. 
system,  competition results in  a  decrease in antibody synthesis against both 
determinants with the anti-R-Azo response being depressed to a  significantly 
greater  extent  than  the  anti-DNP  response.  Furthermore,  the  sum  of  the 
amounts  of anti-DNP  and  anti-R-Azo antibody formed when  both  haptens 
are presented simultaneously is significantly less than  (P  <  0.05  by Student's 
I  test)  the amount  of antibody formed against either hapten presented alone. 86  CONTROL  OF  ANTIBODY  SYNTHESIS 
Furthermore, the degree of depression of antibody synthesis is identical whether 
the two haptens are presented on the same carrier molecule  (R-Azou-DNP~- 
RGG) or on separate carrier molecules (a mixture of DNP28-RGG and R-Azom 
RGG). 
TABLE III 
Effect of Anti-Arsenilate Antibody upon the Response of Rabbits to the Dinitrophenyl 
and the Arsenilate ttaptenic Determinants* 
Antigen 
R-Azo-RGG 
+ 
DNP-RGG 
Average 
R-Azo-DNP-RGG 
Average 
Rabbit 
No. 
2-79 
2-80 
2-81 
2-82 
2-83 
2-07 
2  -08 
2-09 
2-10 
2-58 
2-59 
2  -60 
2-61 
2-62 
Day  13 
Anti-DNP  Anti-R-Azo 
mg/ml  mg/ml 
0.14  0.00 
0.43  0.00 
0.64  0.02 
0.58  0.00 
0.42  0.00 
0.44  <0.01 
0.07  0.04 
0.08  0.05 
0.52  0.05 
0.15  0.05 
0.26  0.03 
0.66  0.03 
0.41  0.08 
0.05  0.08 
0.16  0.04 
0.26  0.05 
Day 20 
Anti-DNP  Anti-R-Azo 
mg/ml  mg/ml 
0.16  0,00 
1.12  0.00 
0.90  0.01 
0.70  0.03 
0.68  0.00 
0.71  0.01 
! 
0.28  0.03 
0.17  0.00 
1.06  0.04 
0.92  0.03 
0.71  0.02 
0.89  0.00 
0.44  0.03 
0.29  0.00 
0.23  i  0.02 
i 
0.56  i  0.02 
* 20 mg of anti-R-Azo antibody given intravenously 1 day before immunization with the 
antigen indicated. Rabbits 2-07-2-10 received purified anti-R-Azo-BGG.  Rabbits 2-58-2-62 
and 2-79-2-83 received anti-R-Azo-RGG antiserum. 
The results of specific  suppression of anti-DNP antibody formation by pas- 
sive antibody upon the immune response to the DNP and R-Azo haptens when 
they are presented  simultaneously, either  on the  same or on separate  carrier 
molecules, are presented in Table II. 20.4  mg of passive  antibody was given 
intravenously 1 day prior to immunization. It can be seen (by comparison with 
Table I)  that under both conditions passive  anti-DNP  antibody results in a 
marked  and  specific  suppression  of  anti-DNP  antibody  synthesis.  Approxi- 
mately 80%  suppression  of  anti-DNP  antibody production was  observed  13 
days after immunization. When immunization was carried out with the doubly 
conjugated antigen R-Azols-DNP~-RGG, suppression  of anti-DNP  antibody N.  I.  BRODY,  J.  G.  WALKER~  AND  G.  W.  SISKIND  87 
synthesis was not accompanied by any change in anti-R-Azo antibody synthe- 
sis. In contrast, when a mixture of DNP~RGG  and R-Azo~-RGG was em- 
ployed, suppression  of anti-DNP  antibody formation with passive  antibody 
resulted in a more than twofold increase in the amount of anti-R-Azo antibody 
produced. This increase was found to be statistically significant (P <  0.01 by 
Student's t test). Thus, suppression of antibody formation against one hapten 
resulted in a  partial elimination of antigenic competition if, and only if, the 
competing antigenic determinants were on different molecules. When the two 
haptens were present on the same carrier molecule, suppression of antibody 
formation against one hapten had no effect upon antibody formation against the 
other. 
Table III indicates the effect of suppressing anti-R-Azo antibody formation 
with passively administered anti-R-Azo  antibody upon  antibody formation 
against DNP  and R-Azo haptens administered simultaneously (cf.  Table I). 
The results obtained were completely compatible with the data discussed above 
(Table II) relating to suppression with anti-DNP antibody. Suppression of the 
response to one hapten resulted in an increased response to the second hapten 
when the two haptens were present on different carrier molecules and had no 
effect on the response to the second hapten when the two determinants were 
present on the same molecule. 
DISCUSSION 
The  experiments  reported  indicate that,  in  the  system studied,  antigenic 
competition between haptenic determinants occurs to the same extent whether 
the two haptens are on the same or on separate carrier molecules. Competition 
resulted in decreased antibody production to both determinants. When deter- 
minants were presented simultaneously, the sum of the amounts of antibody 
formed against each determinant was significantly less than that formed to 
either determinant presented alone. It was further shown that suppression of 
antibody formation to one determinant by passive antibody partially eliminated 
the  depressive  effects of antigenic competition when the  two haptens  were 
located on separate carrier molecules but had no effect on antibody production 
to the second hapten when the two determinants were present on the same 
molecule. 
Suppression of antibody formation by passive antibody is assumed to involve 
binding of antigen, but the detailed mechanism is still not understood. Two 
general possibilities exist: (a) the binding of antigenic determinants by antibody 
results in a rapid clearance and destruction of antigen molecules by phagocytic 
cells and thus prevents antigen molecules from reaching sites essential for the 
initiation of antibody synthesis,  or (b) the binding of antigenic determinants pre- 
vents interaction of the determinant with some receptor site and thus prevents 
initiation of antibody formation. If the first possibility were correct, it would be 88  CONTROL  OF  ANTIBODY  SYNTHESIS 
expected that suppression of antibody formation against an antigen would be 
"molecule specific": that is, antibody against any determinant would result in 
opsonization and rapid clearance of the entire antigenic molecule with conse- 
quent suppression of antibody synthesis to all antigenic determinants present 
on the molecule. This hypothesis has been tested. It was found that with two 
determinants  present  on  one  molecule,  suppression  of  antibody  formation 
against one determinant clearly does not suppress antibody formation against 
the second determinant. We feel that these findings conclusively exclude the 
first hypothesis. Thus, simple phagocytosis and elimination of antigen prior to 
reaching antibody-forming sites cannot account for immunological suppression. 
The second possibility is consistent with all available data. 
As we have discussed previously (16),  the stimulation of immunocompetent 
cells to proliferate and produce antibody may be dependent upon the interac- 
tion of antigen with preformed "antibody" present on or in these cells. Such a 
"selection" theory presumes that cells precommitted to respond to a particular 
antigen are present in the animal prior to contact with antigen. Whether the 
"antigen" triggering such a cell is "native" or in some manner "processed" can- 
not be stated at present. Furthermore, the nature of the "antibody" associated 
with such precommitted cells is totally unknown. It is hypothesized that this 
cell-associated "antibody" has a binding site identical with that of the antibody 
molecules to be produced by the cell  after interaction with antigen. Such a 
theory is consistent with the mechanism of suppression discussed above. Pas- 
sively  administered  antibody  competes  with  "cell-associated antibody" for 
available antigen molecules. Once bound to circulating antibody, the antigenic 
determinant is no longer available for binding to  "cell-associated antibody" 
and thus is incapable of triggering cell proliferation and antibody synthesis. 
This theory would imply (a)  that a  second determinant present on the same 
antigen molecule should be relatively unaffected by the binding of antibody to 
one determinant, and (b)  that the ability of antibody to suppress should be 
related to its binding affinity for the homologous haptenic determinant. The 
first prediction was tested and confirmed by the experiments reported in the 
present paper. Findings to be reported elsewhere are consistent with the second2 
The  mechanism of  antigen competition is  still  not  understood.  That  the 
locus of competition is at the level of the antibody-forming cell itself is incon- 
sistent with any selectional theory of antibody synthesis which presumes pre- 
committed cells each of which is competent to produce only a single or a very 
small number of antibodies of different specificity. If we assume, as appears 
reasonable at present, a selectional theory of antibody synthesis, we are forced 
to conclude that antigenic competition occurs at some step in the antibody- 
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forming mechanism prior to the antibody-synthesizing cell. It has been sugges- 
ted by previous workers  (17)  that some variety of "processing" of antigen, 
perhaps in macrophages, is required prior to the initiation of antibody synthesis. 
Presumably, it would be at some point in this "processing" step that antigenic 
competition occurs. It is clear from the data presented that antigenic competi- 
tion and suppression by passive antibody occur at different steps in the sequence 
of events leading to antibody synthesis. The step affected by passive antibody 
appears to involve specifically the antigenic determinant. In contrast, the step 
involved in antigenic competition appears to involve more of the antigen mole- 
cule than the specific determinant. It is difficult to visualize how the differences 
in behavior seen when the two determinants were on the same or on different 
molecules could be explained purely on the level of antibody specificity. 
The  finding reported  that  two  haptenic  determinants  exhibit equivalent 
competition whether they are located on the same or on different carrier mole- 
cules may be purely fortuitous. This is suggested by the observation recently 
reported by Arnkraut et al.  (18)  that, in their systems, competition occurred 
only when both haptens were on the same carrier molecule. Thus, the results 
obtained in such comparisons may be dependent upon a variety of variables, 
e.g., nature of the two haptens, nature of the carrier molecules, degree of sub- 
stitution, dose of antigens used in immunization, etc. 
Uhr  has  suggested  that  circulating antibody operates  through  a  type  of 
"feedback" mechanism in the control of antibody synthesis (3, 4). By combining 
with antigen, circulating antibody would function in limiting the immune re- 
sponse and prevent uneconomical hyperimmunization. Our studies suggest an 
additional regulatory function for circulating antibody in shifting the specificity 
of the immune response under certain circumstances. Most important, naturally 
occurring antigenic materials (e.g., bacteria) contain a variety of determinants 
located both on the same and on different molecules. When an infected animal 
is presented with a variety of antigens elaborated by any bacteria, antigenic 
competition would be expected to limit the response to some or all of these anti- 
gens. It is known that with certain bacteria, antibodies directed against some 
antigens  can  provide  significant protection  while  antibodies  against  other 
antigenic determinants of these organisms are ineffective. If the initial anti- 
bodies formed by an infected host should have specificities ineffective in con- 
ferring protection, a  mechanism to shift the immune response towards other 
antigenic determinants would be very advantageous. Under these circumstances 
the intial circulating antibody response would serve to suppress further anti- 
body formation to these antigens and would, as demonstrated here, increase the 
antibody response to other antigens. A control mechanism which encouraged a 
shift of the immune response towards different antigens if an infection failed to 
be controlled by the initial immune response would, of course, be highly ad- 
vantageous to the animal. 90  CONTROL  OF  ANTIBODY  SYNTHESIS 
SIYM'MARY 
In the  system studied,  antigenic  competition between  two haptenic  deter- 
minants was found to be of the same extent whether the haptens were on the 
same or on separate carrier molecules. Suppression of antibody formation to one 
determinant  by  administration  of passive  antibody partially  eliminated  the 
depressive effects of antigenic competition when the two haptens were located 
on separate carrier molecules but had no effect on antibody production to the 
second hapten when the two determinants were present on the same molecule. 
The results are discussed in terms of the mechanisms of suppression, antigenic 
competition, and control of antibody formation. 
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